VivoSeq
Other

Microbiota

0

Pipeline Programs↗

7

Active Trials↗

3

Companies Involved↗

Microbiota is an early-stage landscape with 0 programs across 3 companies. The most active players are Spero Therapeutics, MaaT Pharma, Shenzhen Xbiome Biotech Co., Ltd..

Intelligence

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

77/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

S

Spero Therapeutics

0 programs

PreclinicalM

MaaT Pharma

0 programs

PreclinicalS

Shenzhen Xbiome Biotech Co., Ltd.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

42

clinical trials

Completed20 · 48%
Unknown status9 · 21%
Recruiting5 · 12%
Terminated4 · 10%
Withdrawn2 · 5%
Not yet recruiting1 · 2%
Other1 · 2%

Clinical Trials

Trial Activity

42 trials

Fecal Microbiota Transplant for Autobrewery Syndrome
Recruiting·MMassachusetts General Hospital·Phase 1·NCT06083142·8 enrolled
The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial
Recruiting·UUniversity of Chicago·Phase 1·NCT06871111·24 enrolled
Valvular Microbiota and Valvulopathy
Recruiting·UUniversity Hospital, Toulouse·N/A·NCT06407128·100 enrolled
Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)
Recruiting·EEmory University·Phase 2·NCT06321536·60 enrolled
Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC
Recruiting·UUniversity of Minnesota·Phase 1·NCT06197308·28 enrolled
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
Active, not recruiting·JJohns Hopkins University·Phase 1·NCT05695196·34 enrolled
Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT)
Not yet recruiting·FFundación GECP·Phase 2·NCT07247786·68 enrolled
Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity
Completed·UUniversity of Washington·Phase 4·NCT02432404·81 enrolled
Changes in Neighbouring Microbiota in Genitourinary Syndrome
Completed·KKoc University Hospital·Phase 4·NCT06633705·31 enrolled
Clinical Evaluation of the Antibacterial Activity of Thioglycosides Extracted from White Mustard - Bamberka in Oral Hygiene. Evaluation of Periodontal Parameters and Oral Microbiota in Patients.
Completed·MMedical University of Warsaw·Phase 1·NCT06908265·113 enrolled
Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women
Completed·WWestern University, Canada·Phase 1·NCT02150655·30 enrolled
Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity
Completed·UUniversity of Washington·Phase 4·NCT02445989·120 enrolled
Epigenetic and Microbiota Modifications
Completed·FFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud·Phase 1·NCT05076656·22 enrolled
Characteristics of the Intestinal Microbiota in Patients With Cancer
Completed·CCentre Georges Francois Leclerc·N/A·NCT03196609·69 enrolled
Initial Combination of Gemigliptin and Metformin on Microbiota Change
Completed·SSeoul National University Bundang Hospital·N/A·NCT02609815·70 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)